Ciaramella Giuseppe's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Dec 23, 2021
- Accession no.
- 0000899243-21-049634
- Filed
- Dec 23, 2021
- Trade date
- Dec 22, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $224.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaramella GiuseppeCIK 0001786322 | Officer (President & CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | MOption exerciseAcquired | +2,607 | $7.22 | +$18,822.54 | 65,380 | Direct | |
| Dec 22, 2021 | Common Stock | SSaleDisposed | −1,216 | $85.39F3 | −$103,834.24 | 64,164 | Direct | |
| Dec 22, 2021 | Common Stock | SSaleDisposed | −1,101 | $86.62F4 | −$95,368.62 | 63,063 | Direct | |
| Dec 22, 2021 | Common Stock | SSaleDisposed | −290 | $87.34 | −$25,328.6 | 62,773 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Common Stock | MOption exerciseDisposed | −2,607 | $0.00 | $0 | 89,646 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.00 to $85.88, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.15 to $86.99, inclusive.
Referenced by the price of 1 transaction in Table I.